Intramyocellular lipid kinetics and insulin resistance

Area of Science:

• Metabolic Physiology
• Skeletal Muscle Biology
• Insulin Resistance Mechanisms

Background:

• Elevated intramyocellular triglyceride (imcTG) content in skeletal muscle is observed in obesity and type 2 diabetes (T2D).
• imcTG excess is strongly correlated with muscle insulin resistance (MIR), but the causal link and underlying pathways remain debated.
• Previous hypotheses suggested imcTG accumulation is a passive marker due to impaired fatty acid oxidation.

Purpose of the Study:

• To investigate the kinetic properties of the intramyocellular triglyceride (imcTG) pool in high fat-induced obesity (HFO).
• To elucidate the mechanisms linking imcTG dynamics to muscle insulin resistance (MIR).
• To propose a forward mechanism explaining the imcTG-MIR correlation.

Main Methods:

• Kinetic studies were employed to analyze the turnover and synthesis rates of imcTG.
• Studies were conducted using a high fat-induced obesity (HFO) model.
• Analysis focused on the dynamic behavior of the imcTG pool and its metabolic consequences.

Main Results:

• The imcTG pool in HFO models is kinetically dynamic, with both accelerated synthesis and turnover.
• A hyperdynamic imcTG pool increases fatty acid availability, potentially suppressing glucose utilization.
• Released fatty acid metabolites from imcTG impair insulin signaling, directly contributing to MIR.

Conclusions:

• Intramyocellular fatty acids and their metabolites released from a dynamic imcTG pool act as a direct link to muscle insulin resistance (MIR).
• A forward mechanism, where imcTG actively contributes to MIR, is proposed, challenging the backward 'marker' hypothesis.
• Targeting imcTG dynamics may offer novel therapeutic strategies for metabolic diseases like T2D.